THE PROCTER & GAMBLE COMPANY
AND SUBSIDIARIES

******************************************

ANNUAL REPORT ON FORM 10-K
TO THE
SECURITIES AND EXCHANGE COMMISSION
FOR THE
YEAR ENDED JUNE 30, 2004

******************************************


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K

ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

(Mark one)
   
For the fiscal year ended June 30, 2004þ Commission File No. 1-434ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the Fiscal Year Ended June 30, 2006
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 1-434
THE PROCTER & GAMBLE COMPANY
One Procter & Gamble Plaza, Cincinnati, Ohio 45202
Telephone (513) 983-1100
IRS Employer Identification No. 31-0411980
State of Incorporation: Ohio


Securities registered pursuant to Section 12(b) of the Act:
   
Title of each class Name of each Exchange on which registered

 
 
 
Common Stock, without Par Value New York, National, Amsterdam, Paris Basle,
Geneva, Lausanne, Zurich, Frankfurt, Brussels

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes þ No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.
Yes o No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yesxþ Noo

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Large accelerated filer þAccelerated filer oNon-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yesxo Nooþ

There were 2,542,231,468 shares of Common Stock outstanding as of July 31, 2004.

The aggregate market value of the voting stock held by non-affiliates amounted to $129$190 billion on December 31, 2003.

2005.

There were 3,175,086,100 shares of Common Stock outstanding as of July 31, 2006.
Documents Incorporated By Reference

Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 20042006 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described herein.

Portions of the Proxy Statement for the 20042006 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described herein.

1


TABLE OF CONTENTS

PART I
Item 1.Business.
Item 1A.Risk Factors.
Item 1B.Unresolved Staff Comments.
Item 2. PropertiesProperties.
Item 3.Legal ProceedingsProceedings.
Item 4.Submission of Matters to a Vote of Security HoldersHolders.
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity SecuritiesSecurities.
Item 6. Selected Financial DataData.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of OperationsOperations.
Item 7A. Quantitative and Qualitative Disclosures About Market RiskRisk.
Item 8. Financial Statements and Supplementary DataData.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial DisclosureDisclosure.
Item 9A. Controls and ProceduresProcedures.
Item 9B. Other Information
PART III
Item 10.Directors and Executive Officers of the RegistrantRegistrant.
Item 11.Executive CompensationCompensation.
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Item 13.Certain Relationships and Related TransactionsTransactions.
Item 14.Principal Accounting Fees and ServicesServices.
PART IV
Item 15. Exhibits, Financial Statement Schedules and Reports on Form 8-KSIGNATURES
SIGNATURESEXHIBIT INDEX
EXHIBIT INDEXEX-10.19
EX-10.1EX-10.24
Exhibit 10.9EX-11
Exhibit 10.10EX-12
Exhibit 11EX-13
Exhibit 12EX-21
Exhibit 13EX-23
Exhibit 21EX-31
Exhibit 23EX-32
Exhibit 31
Exhibit 32
Exhibit 99-2
Exhibit 99.3
Exhibit 99-4
Exhibit 99-5
Exhibit 99-6
Exhibit 99-7
Exhibit 99-8
Exhibit 99.9
Exhibit 99-10EX-99.1


PART I

Item 1.Business.Business

.

     Additional information required by this item is incorporated herein by reference to Management’s Discussion and Analysis, which appears on pages 29-43;25-40; Note 3, Acquisitions and Spin-Off,1, Summary of Significant Accounting Policies, which appears on pages 52-54;46-49; Note 5, Supplemental Financial Information,2, Acquisitions, which appears on page 55;pages 49-50; and Note 12, Segment Information, which appears on pages 65-6661-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2004.

2006. Unless the context indicates otherwise, the terms the “Company,” “P&G,” “we,” “our” or “us” as used herein refers to The Procter & Gamble Company (the registrant) and its subsidiaries.

     The Procter & Gamble Company is focused on providing branded consumer goods products of superior quality and value to improve the lives of the world’s consumers. The Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, we market over 300 brandedour products in more than 160180 countries. Unless the context indicates otherwise, the terms the “Company,” “we,” “our” or “us” as used herein refers to The Procter & Gamble Company (the registrant) and its subsidiaries.

     The Company manages its business in five product segments: Fabric and Home Care; Baby and Family Care; Beauty Care; Health Care; and Snacks and Beverages. None of these segments is highly seasonal. Many of the factors necessary for an understanding of these five segments are similar. Operating margins of the individual segments vary slightly due to nature of the materials and processes used to manufacture the products, the capital intensity of the businesses and differences in selling, general and administrative expenses as a percent of net sales. Net sales growth by segment is also expected to vary slightly due to the underlying growth of the markets of each segments’ products. For example, we expect the Beauty Care and Health Care segments to provide a disproportionate percentage of overall Company net sales growth, as the market for these products is expected to grow at a higher rate than the remaining segments.

     The markets in which our products are sold are highly competitive. The products of the Company’s business segments compete with products of many large and small companies, including well-known global competitors. We market our products with advertising, promotions and other vehicles to build awareness of our brands in conjunction with an extensive sales force. We believe this combination provides the most efficient method of marketing for these types of products. Product quality, performance, value and packaging are also important competitive factors.

     Throughout this Form 10-K, we incorporate by reference information from other documents filed with the Securities and Exchange Commission (SEC).

     The Company’s annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K are filed electronically with the SEC. The SEC maintains an internet site that contains these reports at:http://www.sec.gov.www.sec.gov The reports. You can also be accessedaccess these reports through links from the Company’sour website at:www.pg.com/investors/sectionmain.jhtml.

     Copies of these reports are also available, without charge, by contacting The Procter & Gamble Company, Shareholder Services Department, P.O. Box 5572, Cincinnati, Ohio 45201-5572.
Financial Information About Segments
     In April 2006, we announced a number of changes to certain key leadership positions, which resulted in changes to our organization structure and segment reporting. These changes dissolved our Family Health Global Business Unit (GBU) by re-aligning the component businesses within our remaining GBU’s. Specifically, Pet Health and Nutrition, which used to be part of our Health Care reportable segment, became part of our Snacks and Coffee reportable segment. The balance of our Health Care reportable segment was combined with the P&G Beauty GBU but will continue to be reported as a separate reportable segment. In addition, our commercial products organization, which primarily sells cleaning products directly to commercial end users, was moved from Snacks and Coffee to the Fabric Care and Home Care reportable segment. Finally, the adult incontinence business was aligned with Feminine Care and as a consequence was removed from Baby Care and Family Care and moved to P&G Beauty. The balance of the Baby Care and Family Care reportable segment was moved from the Family Health GBU to the Household Care GBU but will continue to be reported as a separate reportable segment.
     In conjunction with these changes, the P&G Beauty GBU was renamed “Beauty and Health,” the Snacks and Coffee reporting segment was renamed “Pet Health, Snacks and Coffee,” P&G Household Care was renamed “Household Care” and the Family Health GBU was

2


eliminated. All financial statements contained in this Form 10-K, including historical financial data, reflect the new segment reporting structure.
     The Company is organized into three Global Business Units: Beauty and Health; Household Care; and Gillette GBU. We have seven reportable segments under U.S. GAAP: Beauty; Health Care; Fabric Care and Home Care; Pet Health, Snacks and Coffee; Baby Care and Family Care; Blades and Razors; and Duracell and Braun. Many of the factors necessary for an understanding of these businesses are similar. Operating margins of the individual businesses vary slightly due to the nature of materials and processes used to manufacture the products, the capital intensity of the businesses and differences in selling, general and administrative expenses as a percentage of net sales. Net sales growth by business is also expected to vary slightly due to the underlying growth of the markets of each business and products. None of our businesses are highly seasonal except Duracell and Braun. The Duracell and Braun segment has a disproportionately high level of sales in the December quarter due to the December holiday season. In addition, anticipation or occurrence of natural disasters, such as hurricanes, can drive unusually high demand for batteries.
     Additional information about our businesses can be found in Management’s Discussion and Analysis, pages 25-27, and Note 12, Segment Information, which appears on pages 61-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2006.
Narrative Description of Business

     Business Model.Model. Our business model relies on the continued growth and success of existing brands and products, andas well as the creation of new products. The markets and industry segments in which we offer our products are highly competitive. Our products are sold in over 180 countries around the world primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We have also expanded our presence in “high-frequency stores,” the neighborhood stores which serve many consumers in developing markets. We work collaboratively with our customers to improve the in-store presence of our products and win the “first moment of truth” when a consumer is shopping in the store. We must also win the “second moment of truth” when a consumer uses the product, evaluates how well it met his or her expectations and whether it was a good value. We believe we must continue to provide new, innovative products and branding to the consumer in order to grow our business. Basic researchResearch and product development activities, designed to enable sustained organic growth, continued to carry a high priority during the past fiscal year. While many of the benefits from these efforts will not be realized until future years, the Company believeswe believe these activities demonstrate itsour commitment to future growth.

     Key Product Categories.CategoriesWe currently have three. In 2006, one product categories that each accountcategory accounted for 10% or more of consolidated net sales. The laundry category constituted approximately 18%16% of net sales for fiscal year 2004,2006, compared to 19%17% of net sales for fiscal year 2005 and 18% in 20032004. In fiscal years 2005 and 19% in 2002.2004, we had three product categories, including the laundry category described above, that accounted for 10% or more of consolidated net sales. The diaper category representsrepresented approximately 11% of consolidatednet sales in 2004, compared to 12% in 2003both 2005 and 2002.2004. The retail hair care category accounted for approximately 11%10% of fiscal year 2004 net sales up from just over 9% in 2003fiscal years 2005 and 2002. The increase in hair care category2004. Fiscal year 2006 net sales ispercentages for the above categories decreased due in part, to the addition of Wella AG (Wella).The Gillette Company on October 1, 2005.

3


     Key Customers.Customers. Our customers include mass merchandisers, grocery stores, membership club stores, drug stores and drughigh-frequency stores. Sales to Wal-Mart Stores, Inc. and its affiliates represent approximately 17%15% of our total revenue compared to 18% in 20032006, 16% in 2005 and 17% in 2002.2004. No other customer represents more than 10% of our net sales. Our top ten customers account for approximately 33%31% of total unit volume in 2006, compared to 32% in 2005 and 33% in 2003 and 35% in 2002.2004. The nature of our business results in no material backlog orders or contracts with the government. We believe our practices related to working capital items for customers and suppliers are consistent with the industry segments in which we compete.

     Sources and Availability of Materials.Materials. Almost all of the raw and packaging materials used by the Company are purchased from others, some of whom are single-source suppliers. SomeWe produce raw materials, primarily chemicals, are produced by the Company for further use in the manufacturing process. In addition, fuel and natural gas are important commodities used in our plants and in the trucks used to deliver our products to customers. The prices we pay for materials and other commodities are subject to fluctuation. When prices for these items change, we may or may not pass on the change to our customers, depending on the magnitude and expected duration of the change. We have, however, recently announced price increasesIn 2006, we increased prices in somemany categories, including tissue, coffee andfabric care, home care, baby care, family care, pet health and nutrition,coffee to recover increases in commodity costs. The Company purchases and produces a substantial variety of raw and packaging materials, no one of which is material to the Company’sour business taken as a whole.

     Trademarks and Patents.Patents. We own or have licenses under patents and registered trademarks which are used in connection with our businessactivity in all segments.businesses. Some of these patents or licenses cover significant product formulation and processing of the Company’sprocesses used to manufacture our products. The trademarks of all major products in each segmentbusiness are registered. In part, the

3


Company’sour success can be attributed to the existence and continued protection of these trademarks, patents and licenses.

Competitive Condition.The markets in which our products are sold are highly competitive. Our products compete against similar products of many large and small companies, including well-known global competitors. We market our products with advertising, promotions and other vehicles to build awareness of our brands in conjunction with an extensive sales force. We believe this combination provides the most efficient method of marketing for these types of products. Product quality, performance, value and packaging are also important competitive factors.
Research and Development Expenditures.Research and development expenditures enable P&G to develop technologies and obtain patents across all categories in order to meet the needs and improve the lives of its consumers. Total research and development expenses were $2,075 million in 2006, $1,940 million in 2005 and $1,802 million in 2004.
     Expenditures for Environmental Compliance.Compliance. Expenditures for compliance with federal, state and local environmental laws and regulations are fairly consistent from year to year and are not material to the Company. No material change is expected in fiscal year 2005.

2007.

     Employees.Employees. The Company has approximately 110,000138,000 employees. The increase of approximately 12,00028,000 employees versus the prior year is primarily related to the addition of Wella.The

4


Gillette Company. During the fiscal year, approximately 2,800 employee positions were eliminated from the Company as a result of the Gillette acquisition.
Financial Information About Foreign and Domestic Operations

     Net sales in the United States account for approximately 46%43% of total net sales. No other individual country had net sales exceeding 10% of total net sales. Operations outside the United States are generally characterized by the same conditions discussed in the description of the business above and may also be affected by additional factors including changing currency values, different rates of inflation, economic growth and political and economic uncertainties and disruptions. CompanyOur sales by geography for the fiscal years ended June 30 were as follows:
            
             2006 2005 2004
 2004
 2003
 2002
 
North America  50%  54%  57%  47%  48%  50%
Western Europe  24%  21%  19%  23%  24%  24%
Northeast Asia  5%  5%  4%  4%  5%  5%
Developing Markets  21%  20%  20%  26%  23%  21%

Developing markets include Latin America, Central & Eastern Europe, China, ASEAN, Australasia, India, the Europe/Middle East and Africa.

Africa, Greater China, and ASEAN/Australasia/India.

     Net sales and assets in the United States and internationally were as follows (in millions):
                                                
 Net Sales (for the year ended June 30)
 Assets (as of June 30)
 Net Sales (for the year ended June 30) Assets (as of June 30)
 2004
 2003
 2002
 2004
 2003
 2002
 2006 2005 2004 2006 2005 2004
United States $23,688 $21,853 $21,198 $23,687 $23,424 $23,434  $29,462 $25,342 $23,688 $75,444 $25,399 $23,687 
International 27,719 21,524 19,040 33,361 20,282 17,342  38,760 31,399 27,719 60,251 36,128 33,361 

Development of the Business

     The discussion below provides insight to the general development of our business, including the material acquisitions and disposition of assets over the past fivethree years.

     Wella.Gillette Acquisition.In March 2003, the Company entered into an agreement to acquire a controlling interest in Wella from the majority shareholders. In September 2003,On October 1, 2005, we completed this purchasethe acquisition of The Gillette Company. Pursuant to the acquisition agreement, which provided for the exchange of 0.975 shares of WellaThe Procter & Gamble Company common stock, on a tax-free basis, for EUR 3.16each share of The Gillette Company, we issued 962 million shares of The Procter & Gamble Company common stock. The value of these shares was determined using the average of Company stock prices beginning two days before and ending two days after January 28, 2005, the date the acquisition was announced. We also issued 79 million stock options in exchange for The Gillette Company’s outstanding stock options. Under the purchase method of accounting, the total consideration was approximately $53.43 billion (approximately $3.42 billion based on exchange rates on that date). Additionally,including common stock, the fair value of vested stock options and acquisition costs.
     The acquisition of The Gillette Company provides us with global market leadership in September 2003, we purchased shares secured through a tender offer to remaining shareholdersmale grooming, selected female grooming products, alkaline batteries and in manual and power toothbrushes. Total sales for EUR 1.49 billion (approximately $1.67

The Gillette Company during its most recent year ended December 31, 2004 were $10.5 billion.

45


billion based

     In order to obtain regulatory approval of the transaction, we were required to divest certain overlapping businesses. We completed the divestiture of the Spinbrush toothbrush business, Rembrandt (a Gillette oral care product line) and Right Guard and other Gillette deodorant brands during the fiscal year ended June 30, 2006.
Juice Divestiture.In August 2004 the Company completed the divestiture of its Juice business.
Wella Acquisition. In September 2003, the Company acquired a controlling interest in Wella. Through a stock purchase agreement with the majority shareholders of Wella and a tender offer made on exchange rates on that date). As a result of these purchases, the Companyremaining shares, we acquired approximately 81% of the outstanding Wella shares (99% of the voting class shares and 45% of the preference shares).

In June 2004, the Company and Wella entered into a Domination and Profit Transfer Agreement (the Domination Agreement). Under the Domination Agreement, we are entitled to exercise full operating control and receive 100% of the future earnings of Wella. As consideration for the Domination Agreement, we will pay the holders of the remaining outstanding sharesshareholders of Wella a guaranteed annual dividend payment. Alternatively, the remaining Wella shareholders may elect to tender their shares to the Company for an agreed price. The fair value of the total guaranteed annual dividend payments iswas $1.11 billion, which is the approximate cost if all remaining shares were tendered.

During the year ended June 30, 2006, a portion of the remaining shares were tendered, resulting in a $944 million reduction in our liability under the Domination Agreement.

     The total purchase price for Wella, including acquisition of Wellacosts, was $6.27 billion based on exchange rates at the acquisition dates. The acquisition was financed by a mixture of available cash balances, debt and debt. Wella is a leading beauty care company selling its products in more than 150 countries, focused on professional hair care, retail hair care and cosmetics and fragrances.

the liability recorded under the Domination Agreement.

     Hutchison Acquisition. In June 2004, we purchased the remaining 20% stake of our China venture from our partner, Hutchison Whampoa China Ltd. (Hutchison), giving the Companyus full ownership of our operations in China. The net purchase price was $1.85 billion, which is the purchase price of $2.00 billion net of minority interest and certain obligations that were eliminated as a result of the transaction. The acquisition was funded by debt.

Jif/Crisco.During May 2002, we completed the spin-off of the Jif peanut butter

Item 1A.Risk Factors.
     We discuss our expectations regarding future performance, events and Crisco shortening brands to the Company’s shareholdersoutcomes, such as our business outlook and their subsequent merger into The J.M. Smucker Company.

Clairol.In November 2001, we completed the acquisition of the Clairol business from The Bristol-Myers Squibb Company.

Restructuring Program.In 1999, the Company announced its intention to transition from its previous geographic-based structure to a product-based global business unit structure. Concurrent with that change, we initiated a multi-year restructuring program, a discussion of which is incorporated herein by reference to Note 2, Restructuring Program, which appears on page 52 ofobjectives in this Form 10-K, the Annual Report to Shareholdersshareholders, quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are “forward-looking statements” and are based on financial data and business plans available only as of the fiscal year ended June 30, 2004.time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations.

     The following discussion of “risk factors” identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with Management’s Discussion and Analysis (MD&A) and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight

6


what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends.
A material change in the demand for our products could have a significant impact on our business.
     We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. This is dependent on a number of factors including our ability to manage and maintain key customer relationships and our ability to develop effective sales, advertising and marketing programs in an increasingly fragmented media environment. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world.
The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors.
     Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition.
Our ability to successfully integrate key acquisitions, primarily Gillette, could impact our business results.
     Since our goals include a growth component tied to acquisitions, we must be able to successfully manage and integrate key acquisitions, such as the acquisition of The Gillette Company. Specifically, we must be able to integrate acquisitions without any significant disruption to our ability to manage and execute business plans on our base businesses. In addition, our financial results could be adversely impacted if we are not able to deliver the expected cost and growth synergies associated with our acquisitions.
Our businesses face cost pressures which could affect our business results.
     Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Our costs in 2006 were impacted by higher commodity costs and this trend is likely to continue in 2007. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements.
We face risks associated with significant international operations.
     We conduct business across the globe with a significant portion of our sales outside the United States. Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty,

7


especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities.
Our business is subject to regulation in the U.S. and abroad.
     Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and intellectual property matters as well as those related to the integration of Gillette and its subsidiaries) and to resolve pending matters within current estimates may impact our results.

Item 1B.Unresolved Staff Comments.
     None.

Item 2.Properties.

     In the United States, the Company ownswe own and operates 37operate 39 manufacturing facilities located in 2123 different states. In addition, the Company ownswe own and operates 99operate 107 manufacturing facilities in 42 other countries. Many of the domestic and international facilities produce products for multiple business segments.businesses. Beauty products are manufactured at 52 of these locations; Health Care products are manufactured at 22 of these locations; Fabric Care and Home Care products are produced at 43 of these locations;43; Baby Care and Family Care products at 31;32; Pet Health, CareSnacks and Coffee products at 22; Beauty Care15; Blades and Razors at 8; and Duracell and Braun products at 64; and Snacks and Beverages products at 11.13. Management believes that the Company’s production facilities are adequate to support the business efficiently and that the properties and equipment have been well maintained.

5


Item 3.Legal Proceedings.

     The Company is involved in clean-up efforts at off-site Superfund locations, many

     We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which are in the preliminary stagescover a wide range of investigation. The amount accrued at the end of June 30, 2004, representing the Company’s probable future costs that can be reasonably estimated, was $8 million.

     The Company is also involved in certain othermatters, including antitrust and trade regulation, product liability, advertising, contracts, environmental proceedings. Noissues, patent and trademark matters, and taxes. Based on currently available information, no such legal proceeding or claim is expected to result in material monetarymaterially impact our financial condition, cash flows or other sanctions being imposed by any governmental entity, or in other material liabilities. In 2003 and thereafter, The Folger Coffee Company, a subsidiaryresults of the Company, voluntarily contacted the Louisiana Department of Environmental Quality (LDEQ) concerning compliance with certain air emission permit requirements at its New Orleans coffee processing plant. As a result of these self-disclosures, the subsidiary expects to receive from the LDEQ an Administrative Order on Consent and anticipates negotiating an agreed penalty with the agency to resolve these issues. No judicial proceeding is pending. The Company’s liability is estimated not to exceed $260,000.operations.

Item 4.Submission of Matters to a Vote of Security Holders.

     Not applicable.

Applicable.

68


Executive Officers of the Registrant

The names, ages and positions held by the executive officers of the Company on September 8, 2004August 29, 2006 are:
               
 Elected to Elected to
Name
 Position
 Age
 Officer Position
 Position Age Officer Position
Alan G. Lafley Chairman of the Board, President and Chief Executive Director since June 8, 2000  57   1992  Chairman of the Board,
President and Chief Executive
Director since June 8, 2000
  59   1992 
                    
Bruce L. Byrnes Vice Chairman of the Board - Global Household Care
Director since April 8, 2002
  56   1991  Vice Chairman of the Board -
Household Care
Director since April 8, 2002
  58   1991 
                    
R. Kerry Clark Vice Chairman of the Board - Global Health, Baby & Family Care
Director since April 8, 2002
  52   1995 
James M. Kilts Vice Chairman of the Board — Gillette
Director since October 11, 2005
  58   2005 
                    
Susan E. Arnold Vice Chairman - Global Beauty Care  50   2004  Vice Chairman — Beauty & Health  52   2004 
                    
Robert A. McDonald Vice Chairman - Global Operations  51   1999  Vice Chairman — Global Operations  53   1999 
          
Mark M. Leckie Group President — Gillette GBU  53   2006 
                    
Richard L. Antoine Global Human Resources Officer  58   1998  Global Human Resources Officer  60   1998 
                    
G. Gilbert Cloyd Chief Technology Officer  58   2000  Chief Technology Officer  60   2000 
                    
Clayton C. Daley, Jr. Chief Financial Officer  52   1998  Chief Financial Officer  54   1998 
                    
R. Keith Harrison, Jr. Global Product Supply Officer  56   2001  Global Product Supply Officer  58   2001 
                    
James J. Johnson Chief Legal Officer and Secretary  57   1991  Chief Legal Officer and Secretary  59   1991 
                    
Mariano Martin Global Customer Business
Development Officer
  51   2003  Global Customer Business Development Officer  53   2003 
                    
Charlotte R. Otto Global External Relations Officer  51   1996  Global External Relations Officer  53   1996 
                    
Filippo Passerini Chief Information Officer and Global Services Officer  47   2003  Chief Information Officer and Global Services Officer  49   2003 
                    
Valarie L. Sheppard Vice President and Comptroller  42   2005 
          
James R. Stengel Global Marketing Officer  49   2001  Global Marketing Officer  51   2001 
          
John K. Jensen Vice President and Comptroller  55   2002 

All of the Executive Officers named above, excluding Messrs. Kilts and Leckie, have been employed by the Company for more than five years. During the previous five years, Mr. Kilts was the Chairman of the Board (January 2001-October 2005), Chief Executive Officer (February 2001-October 2005) and President (November 2003-October 2005) of The Gillette Company.

All of the Executive Officers named above have been employed by the Company for more than five years.

79


During the previous five years, Mr. Leckie was employed by The Gillette Company as President — Global Business Management, Duracell (April 2001-April 2004), President — Global Business Management, Duracell and Braun (April 2004-October 2005) and President — Global Duracell and Braun (October 2005-July 2006).

10


PART II

Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

ISSUER PURCHASES OF EQUITY SECURITIES
                 
          Total number of Maximum number
          shares purchased as of shares that may
          part of publicly yet be purchased
  Total number of Average price paid announced plans or under the plans or
Period
 shares purchased(1)
 per share(2)
 programs(3)
 programs(3)
4/1/04 - 4/30/04  8,592,314  $52.79   0   0 
5/1/04 - 5/31/04  13,545,020  $53.19   0   0 
6/1/04 - 6/30/04  10,316,911  $54.84   0   0 
                 
              Approximate Dollar
          Total Number of Value of Shares
          Shares Purchased as That May Yet be
          Part of Publicly Purchased Under Our
  Total Number of Average Price Announced Share Repurchase
  Shares Paid per Plans or Program
Period Purchased(1) Share(2) Programs (3)(4) ($ in Billions)
                 
4/1/06-4/30/06  58,539,546  $58.44   58,539,546   3 
                 
5/1/06-5/31/06  39,557,578  $56.17   39,557,578   0.8 
                 
6/1/06-6/30/06  10,780,118  $54.52   10,743,308   0.2(5)

(1) All share repurchases were made in open-market transactions. None of these transactions were made pursuant to a publicly announced repurchase plan. This table excludescategory includes 36,810 shares withheld from employees to satisfy minimum tax withholding requirements on option exercisesacquired by the Company under various compensation and other equity-based transactions.benefit plans. The Company administers employee cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercises.exercise.
 
(2) Average price paid per share is calculated on a settlement basis and excludes commission.
 
(3) NoOn July 21, 2006, the Company completed its share repurchases werebuyback plan previously announced in connection with the Gillette acquisition. Total shares repurchased under the plan amounted to $20.1 billion which was consistent with our stated estimate of about $20 billion. Following completion of this plan, the Company expects that any further repurchase of shares will be made pursuant toon a publicly announced plan or program. The Company’s strategy for cash flow utilization is to pay dividends first and then repurchase Company common stock to cover option exercises made pursuant to the Company’s stock option programs. The remaining cash is then available for strategic acquisitions and discretionary repurchasebasis as part of the Company’s common stock.overall cash management strategy, which also includes capital expenditures, dividends, debt service, and strategic acquisitions.
(4)The Company entered into a forward purchase agreement to repurchase an additional 36,838,164 shares, at an average price of $59.45 per share during the quarter ending March 31, 2006, that settled in April 2006 and is reflected in the table above.
(5)The fiscal year ending balance was purchased in July 2006.

     Additional information required by this item is incorporated by reference to Shareholder Information, which appears on page 7066 of the Annual Report to Shareholders for the fiscal year ended June 30, 2004,2006, and Part III, Item 12 of this Annual Report on Form 10-K.

Item 6.Selected Financial Data.

     The information required by this item is incorporated by reference to Note 1, Summary of Significant Accounting Policies, which appears on pages 50-52;46-49; Note 12, Segment Information, which appears on pages 65-66;61-62; and Financial Summary, which appears on page 67 of the Annual Report to Shareholders for the fiscal year ended June 30, 2004.2006.

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

     The information required by this item is incorporated by reference to Management’s Discussion and Analysis, which appears on pages 29-43;25-40; Note 1, Summary of Significant Accounting Policies, which appears on pages 50-52;46-49; Note 2, Restructuring Program, which appears on page 52; Note 3, Acquisitions, and Spin-Off, which appears on pages 52-54;49-50; Note 11, Commitments and Contingencies, which appears on page 64;pages 60-61; and Note 12, Segment Information,

811


Note 12, Segment Information, which appears on pages 65-6661-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2004.

2006.

     The Company has made certain forward-looking statements in the Annual Report to Shareholders for the fiscal year ended June 30, 20042006 and in other contexts relating to volume and net sales growth, increases in market shares, financial goals and cost reduction, among others.

     These forward-looking statements are based on assumptions and estimates regarding competitive activity, pricing, product introductions, economic conditions, customer and consumer trends, technological innovation, currency movements, governmental action and the development of certain markets available at the time the statements are made. Among theThere are a number of key factors that could impact results and must be managed by the Company are:

(1)the ability to achieve business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which the Company has chosen to focus;
(2)successfully executing, managing and integrating key acquisitions (including the Domination and Profit Transfer Agreement with Wella);
(3)the ability to manage and maintain key customer relationships;
(4)the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources);
(5)the ability to successfully manage regulatory, tax and legal matters (including product liability matters), and to resolve pending matters within current estimates;
(6)the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the success of the Company’s outsourcing projects;
(7)the ability to successfully manage currency (including currency issues in volatile countries), interest rate and certain commodity cost exposures;
(8)the ability to manage the continued global political and/or economic uncertainty and disruptions, especially in the Company’s significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities;
(9)the ability to successfully manage increases in the prices of raw materials used to make the Company’s products;
(10)the ability to stay close to consumers in an era of increased media fragmentation; and
(11)the ability to stay on the leading edge of innovation.

     If the Company’s assumptions and estimates are incorrect or do not come to fruition, or if the Company does not achieve all of these key factors, thencause our actual results mightto materially differ materially from the forward-looking statements made herein.

9

herein and in other contexts. Please see Item 1A “Risk Factors” of this Form 10-K for a discussion of these important factors.


Item 7A.Quantitative and Qualitative Disclosures About Market Risk.

     The information required by this item is incorporated by reference to the section entitled Other Information, which appears on pages 42-43,39-40, and Note 7,6, Risk Management Activities, which appears on pages 56-5752-53 of the Annual Report to Shareholders for the fiscal year ended June 30, 2004.2006.

Item 8.Financial Statements and Supplementary Data.

     The financial statements and supplementary data are incorporated by reference to pages 44-6741-68 of the Annual Report to Shareholders for the fiscal year ended June 30, 2004.2006.

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

     Not applicable.

Item 9A.Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.
     The Company’s Chairman of the Board, President and Chief Executive, A.G.A. G. Lafley, and the Company’s Chief Financial Officer, Clayton C. Daley, Jr., have evaluatedperformed an evaluation of the Company’s internal controldisclosure controls and disclosure control systemsprocedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (“Exchange Act”)) as of the end of the period covered by this report.

Annual Report on Form 10-K.

     Messrs. Lafley and Daley have concluded that the Company’s disclosure control systemscontrols and procedures are functioning effectively to provide reasonable assurance that the Company can meet its disclosure obligations. The Company’s disclosure control system is based upon a global chain of financial, staff and general business reporting lines that converge in the worldwide headquarters of the Company in Cincinnati, Ohio. The reporting process is designed to ensure that information required to be disclosed by the Company in the reports that it files or submits with the Commission is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Consistent with SEC suggestion, the Company has formed a Disclosure Committee consisting of key Company personnel designed to review the accuracy and completeness of all disclosures made by the Company.

     In connection with the evaluation described above, no changes in the Company’seffectively.

Management’s Report on Internal Control over Financial Reporting.
     Management’s annual report on internal control over financial reporting and the report of the independent registered public accounting firm are incorporated by reference to page 23 of the Annual Report to Shareholders for the fiscal year ended June 30, 2006. This report includes the businesses acquired through the acquisition of The Gillette Company in October 2005.

12


Changes in Internal Control Over Financial Reporting.
     There were no changes in our internal control over financial reporting that occurred during the Company’s fourth fiscal quarter that hashave materially affected, or isare reasonably likely to materially affect, the Company’s internal control over financial reporting.

Item 9B.Other Information.
     James M. Kilts, Vice Chairman of the Board — Gillette, has announced his intention to retire as an Officer and Director of the Company effective October 1, 2006.

1013


PART III

Item 10.Directors and Executive Officers of the Registrant.

     John F. Smith, Jr. is the Chairman of the Audit Committee.

     The Board of Directors has determined that Mr. John F. Smith, isJr., Chairman of the Audit Committee, and Mr. Charles R. Lee, Audit Committee member, are both independent and anare audit committee financial expert,experts, as defined by SEC guidelines.

     Additional

     The information required by this item is incorporated by reference to pages 4-9, up to but not including the section entitled Additional Information Concerning the Board of Directors;and Committee Meeting Attendance; to the section entitled Code of Ethics, which appears on page 10; and to the section entitled Section 16(a) Beneficial Ownership Reporting Compliance, which appears on pages 27-2832-33 of the Proxy Statement filed since the close of the fiscal year ended June 30, 2004,2006, pursuant to Regulation 14A which involved the election of directors. Pursuant to Instruction 3 of Item 401(b) of Regulation S-K, Executive Officers of the Registrant are reported in Part I of this report.

Item 11.Executive Compensation.

     The information required by this item is incorporated by reference to pages 9-249-29 of the Proxy Statement filed since the close of the fiscal year ended June 30, 2004,2006, pursuant to Regulation 14A which involved the election of directors, beginning with the section entitled Additional Information Concerning the Board of Directors.and Committee Meeting Attendance.

Item 12.Security Ownership of Certain Beneficial Owners and Management.Management and Related Stockholder Matters.

     The following table gives information about the Company’s common stock that may be issued upon the exercise of options, warrants and rights under all of the Company’s equity compensation plans as of June 30, 2004.2006. The table includes the following plans: The 1968 Procter & Gamble Plan for the Use of Shares in Payment of Remuneration; The Procter & Gamble 1992 Stock Plan; The Procter & Gamble 1992 Stock Plan (Belgian Version); The Procter & Gamble 1993 Non-Employee Directors’ Stock Plan; The Procter & Gamble Future Shares Plan; The Procter & Gamble 2001 Stock and Incentive Compensation Plan; and The Procter & Gamble 2003 Non-Employee Directors’ Stock Plan; The Gillette Company 1971 Stock Option Plan and The Gillette Company 2004 Long-Term Incentive Plan.
                        
 Number of securities Number of securities 
 remaining available for remaining available for 
 future issuance under Number of securities to be Weighted-average exercise future issuance under 
 Number of securities to Weighted-average equity compensation issued upon exercise of price of outstanding equity compensation plans 
 be issued upon exercise exercise price of plans (excluding outstanding options, options, warrants and (excluding securities 
 of outstanding options, outstanding options, securities reflected in warrants and rights rights reflected in column (a)) 
Plan Category
 warrants and rights
 warrants and rights
 column (a))
 (a) (b) (c) 
Equity compensation plans approved by security holders(1)
 348,490,236 $43.85 117,913,936 
 (a)
 (b)
 (c)
 
Equity compensation plans approved by security holders(1)
 255,703,502 $38.68 159,738,239 
Equity compensation plans not approved by security holders(2)
 20,589,116 $40.97 5,660,800  17,055,054 $41.88 5,117,192 
 
 
 
 
 
 
        
Total 276,292,618 $38.85 165,399,039  365,545,290 $43.76 123,031,128 
 
 
 
 
 
 
        

11


(1) Includes The 1968 Procter & Gamble Plan for the Use of Shares in Payment of Remuneration; The Procter & Gamble 1992 Stock Plan; The Procter & Gamble 1993 Non-Employee Directors’ Stock Plan; The Procter & Gamble 2001 Stock and Incentive Compensation Plan; and The Procter & Gamble 2003 Non-Employee

14


Directors’ Stock Plan; The Gillette Company 1971 Stock Option Plan and The Gillette Company 2004 Long-Term Incentive Plan.
 
(2) Includes The Procter & Gamble 1992 Stock Plan (Belgian Version) and The Procter & Gamble Future Shares Plan.

The Procter & Gamble 1992 Stock Plan (Belgian Version)

     Effective February 14, 1997,

     No further grants can be made under the plan, although unexercised stock options previously granted under this plan remain outstanding. This plan was approved by the Company’s Board of Directors approved The Procter & Gamble 1992 Stock Plan (Belgian Version).on February 14, 1997. Although the plan has not been submitted to shareholders for approval, the planit is nearly identical to The Procter & Gamble 1992 Stock Plan, approved by the Company’s shareholders on October 13, 1992, except for a few minor changes designed to comply with the Belgian tax laws. Although no further grants can be made under the plan, unexercised stock options previously granted under this plan remain outstanding.

     The plan is a stock incentive planwas designed to attract, retain and motivate key Belgian employees. Under the plan, eligible participants may bewere: (i) granted or offered the right to purchase stock options, may be(ii) granted stock appreciation rights and/or may be(iii) granted shares of the Company’s common stock. Except in the case of death of the recipient, all stock options and stock appreciation rights must vest in no less than one year from the date of grant and must expire no later than fifteen years from the date of grant. The exercise price for all stock options granted under the plan is the average price of the Company’s stock on the date of grant. If a recipient of a grant leaves the Company while holding an unexercised option or right, any unexercisable portions immediately become void, except in the case of death, and any exercisable portions become void within one month of departure, except in the case of death or retirement. Any common stock awarded under the plan may be subject to restrictions on sale or transfer while the recipient is employed, as the committee administering the plan may determine.

The Procter & Gamble Future Shares Plan

     On October 14, 1997, the Company’s Board of Directors approved The Procter & Gamble Future Shares Plan pursuant to which options to purchase shares of the Company’s common stock may be granted to employees worldwide. The purpose of this plan is to advance the interests of the Company by giving substantially all employees a stake in the Company’s future growth and success and to strengthen the alignment of interests between employees and the Company’s shareholders through increased ownership of shares of the Company’s stock. The plan has not been submitted to shareholders for approval.

     Subject to adjustment for changes in the Company’s capitalization, the number of shares to be granted under the plan is not to exceed 17 million shares. Under the plan’s regulations, recipients are granted options to acquire 100 shares of the Company’s common stock at an exercise price equal to the average price of the Company’s common stock on the date of the grant. These options vest five years after the date of grant and expire ten years following the date of grant. If a recipient leaves the employ of the Company prior to the vesting date for a reason other than disability, retirement or special separation (as defined in the plan), then the award is forfeited.

     At the time of the first grant following Board approval of the plan, each employee of the Company not eligible for an award under the 1992 Stock Plan was granted options for 100 shares. SinceFrom the date of thethis first grant through June 30, 2003, each new employee of the Company has also received options for 100 shares. Following the grant of options on June 30,

15


2003, the Company suspended this part of the plan and intends to make no further grants under this part of the plan.

12


     In addition to the grants above, annual grants of options for 100 shares are granted to approximately 2,0003,000 employees who are not eligible for participation in the 2001 Stock and Incentive Compensation Plan in recognition of outstanding performance.

The Company’s key managers are not eligible for such grants.

     Additional information required by this item is incorporated by reference to pages 25-2730-32, up to but not including the section entitled Section 16(a) Beneficial Ownership Reporting Compliance, of the Proxy Statement filed since the close of the fiscal year ended June 30, 2004,2006, pursuant to Regulation 14A which involved the election of directors, including footnotes referenced therein.

Item 13.Certain Relationships and Related Transactions.

     The information required by this item is incorporated by reference to the section entitled Transactions with Executive Officers, Directors and Others, which appears on page 2834 of the Proxy Statement filed since the close of the fiscal year ended June 30, 2004,2006, pursuant to Regulation 14A which involved the election of directors.

Item 14.Principal Accounting Fees and Services.

     The information required by this item is incorporated by reference to pages 28-3034-36 of the Proxy Statement filed since the close of the fiscal year ended June 30, 2004,2006, pursuant to Regulation 14A which involved the election of directors, beginning with the section entitled Report of the Audit Committee up to but not including the section entitled Proposal to Ratify Appointment of the Independent Registered Public Accounting Firm.

1316


PART IV

Item 15.Exhibits and Financial Statement Schedules and Reports on Form 8-K.Schedules.

 
A. 1. Financial Statements:
 
 
  The following consolidated financial statementsConsolidated Financial Statements of The Procter & Gamble Company and subsidiaries, management’s report and the reports of the independent auditors’ reportregistered public accounting firm are incorporated by reference in Part II, Item 8.8 of this Form 10-K.
Management’s Report on Internal Control over Financial Reporting
  Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting
-Independent Auditors’ Report
  Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements
 
- Consolidated statementsStatements of earningsEarnings — for years ended June 30, 2004, 20032006, 2005 and 20022004
 
- Consolidated balance sheetsBalance Sheets — as of June 30, 20042006 and 20032005
 
- Consolidated statementsStatements of shareholders’ equityShareholders’ Equity — for years ended June 30, 2004, 20032006, 2005 and 20022004
 
- Consolidated statementsStatements of cash flowsCash Flows — for years ended June 30, 2004, 20032006, 2005 and 20022004
 
- Notes to consolidated financial statementsConsolidated Financial Statements
 
2. Financial Statement Schedules:
 
 
  These schedules are omitted because of the absence of the conditions under which they are required or because the information is set forth in the financial statements or notes thereto.
Exhibits:
     
Exhibit Exhibits:
(3-1) 
Exhibit (3-1)  Amended Articles of Incorporation (Incorporated by reference to Exhibit (3-1) of the Company’s Annual Report on Form 10-K10-Q for the yearquarter ended JuneSeptember 30, 2003)2005).
   
(3-2) Regulations (Incorporated by reference to Exhibit (3-2) of the Company’s Annual Report on Form 10-K10-Q for the yearquarter ended JuneSeptember 30, 2003)2005).
   
Exhibit(4) Registrant agrees to file a copy of documents defining the rights of holders of long-term debt upon request of the Commission.
   
Exhibit(10-1) The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended December 10, 2002)on February 14, 2006) which was adopted by shareholders at the annual meeting on October 9, 2001 (Incorporated by reference to Exhibit (10-1) of the Company’s Form 10-Q for the quarter ended March 31, 2006), and related correspondence and terms and conditions.conditions (Incorporated by reference to Exhibit (10-2) of the Company’s Form 10-Q for the quarter ended March 31, 2006).*

17


   
(10-2) The Procter & Gamble 1992 Stock Plan (as amended December 11, 2001) which was adopted by the shareholders at the annual meeting on October 12, 1992 (Incorporated by reference to Exhibit (10-2) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).*
   
(10-3) The Procter & Gamble Executive Group Life Insurance Policy (each executive officer is covered for an amount equal to annual salary plus bonus) (Incorporated by reference to Exhibit (10-3) of the

14


Company’s Annual Report on Form 10-K for the year ended June 30, 2003).*
   
(10-4) Additional Remuneration Plan (as amended July 11, 2000) which was adopted by the Board of Directors on April 12, 1949, and related correspondence and terms and conditions (Incorporated by reference to Exhibit (10-4) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2000)2005).*
   
(10-5) The Procter & Gamble Deferred Compensation Plan for Directors which was adopted by the Board of Directors on September 9, 1980 (Incorporated by reference to Exhibit (10-5) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).*
   
(10-6) The Procter & Gamble 1993 Non-Employee Directors’ Stock Plan (as amended September 10, 2002) which was adopted by the shareholders at the annual meeting on October 11, 1994 (Incorporated by reference to Exhibit (10-6) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).*
   
(10-7) The Procter & Gamble 1992 Stock Plan (Belgian Version) (as amended December 11, 2001) which was adopted by the Board of Directors on February 14, 1997 (Incorporated by reference to Exhibit (10-7) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).*
   
(10-8) The Procter & Gamble Future Shares Plan (as amended June 10, 2003)adjusted for the stock split effective May 21, 2004) which was adopted by the Board of Directors on October 14, 1997 (Incorporated by reference to Exhibit (10-8)(10-2) of the Company’s Form 10-Q for the quarter ended March 31, 2005).*
(10-9)The Procter & Gamble 2003 Non-Employee Directors’ Stock Plan (as adjusted for the stock split effective May 21, 2004) which was adopted by the shareholders at the annual meeting on October 14, 2003 (Incorporated by reference to Exhibit (10-3) of the Company’s Form 10-Q for the quarter ended March

18


31, 2005), and related correspondence and terms and conditions (Incorporated by reference to Exhibit (10-9) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003)2004).*
   
(10-9) — The Procter & Gamble 2003 Non-Employee Directors’ Stock Plan, and related correspondence and terms and conditions.*
   
(10-10) The Procter & Gamble Company Executive Deferred Compensation Plan.Plan (Incorporated by reference to Exhibit (10-1) of the Company’s Form 10-Q for the quarter ended December 31, 2005).*
   
(10-11)Summary of the Company’s Short Term Achievement Reward Program and Business Growth Program, and related correspondence and terms and conditions (Incorporated by reference to Exhibit (10-11) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2005).*
(10-12)Summary of personal benefits available to certain officers and non-employee directors (Incorporated by reference to Exhibit (10-12) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2005).*
(10-13)$24,000,000,000 Revolving Credit Agreement among Procter & Gamble International S.a.r.l and a syndicate of banks led by Citigroup (Incorporated by reference to Exhibit (10-13) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2005).
(10-14)The Gillette Company 1971 Stock Option Plan (Incorporated by reference to Exhibit (10-2) of the Company’s Form 10-Q for the quarter ended December 31, 2005).*
(10-15)The Gillette Company 2004 Long-Term Incentive Plan (Incorporated by reference to Exhibit (10-3) of the Company’s Form 10-Q for the quarter ended December 31, 2005).*
(10-16)Amended and Restated Employment Agreement, dated December 23, 2004, between The Gillette Company and James M. Kilts (Incorporated by reference to Exhibit 10(g) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).*
(10-17)Amendment No. 1 to the Amended and Restated Employment Agreement dated as of December 23, 2004, entered into as of January 27, 2005, between The Gillette Company and James M. Kilts (Incorporated by reference to Exhibit 10.2 of the Form 8-K filed by The Gillette Company on January 28, 2005, Commission File No. 1-922).*

19


(10-18)Stock Option Agreement, dated January 19, 2001, between The Gillette Company and James M. Kilts, filed as Exhibit A to the Amended and Restated Employment Agreement between The Gillette Company and James M. Kilts (Incorporated by reference to Exhibit 10(g) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).*
(10-19)The Gillette Company Executive Life Insurance Program.
(10-20)The Gillette Company Personal Financial Planning Reimbursement Program (Incorporated by reference to Exhibit 10(o) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922)*
(10-21)The Gillette Company Senior Executive Financial Planning Program (Incorporated by reference to Exhibit 10(p) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).*
(10-22)The Gillette Company Estate Preservation Plan (Incorporated by reference to Exhibit (10-22) of the Company’s Form 10-Q for the quarter ended December 31, 2005).*
(10-23)The Gillette Company Deferred Compensation Plan (Incorporated by reference to Exhibit 10(t) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).*
(10-24)Employment Agreement dated July 28, 2006 between The Procter & Gamble Company and Mark M. Leckie.*
Exhibit(11) Computation of earnings per share.
   
Exhibit(12) Computation of ratio of earnings to fixed charges.
   
Exhibit(13) Annual Report to Shareholders (pages 1-70)1-68).
   
Exhibit(21) Subsidiaries of the registrant.
   
Exhibit (23) — Independent Auditors’ Consent.
   
Exhibit(23)Consent of Independent Registered Public Accounting Firm.
Exhibit(31) Rule 13a-14(a)/15d-14(a) Certifications.
   
Exhibit(32)Section 1350 Certifications.

1520


   
Exhibit (32) — Section 1350 Certifications.
   
Exhibit(99-1) Summary of Directors and Officers Liability Policy (Incorporated by reference to Exhibit (99-1) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2001).Insurance Program.
* 
(99-2) —Directors and Officers (First) Liability Binder of Insurance.
(99-3) —Directors and Officers (Second) Liability Binder of Insurance.
(99-4) —Directors and Officers (Third) Liability Binder of Insurance.
(99-5) —Directors and Officers (Fourth) Liability Binder of Insurance.
(99-6) —Directors and Officers (Fifth) Liability Binder of Insurance.
(99-7) —Directors and Officers (Sixth) Liability Binder of Insurance.
(99-8) —Directors and Officers (Seventh) Liability Binder of Insurance.
(99-9) —Directors and Officers (Eighth) Liability Binder of Insurance.
(99-10) —Directors and Officers (Ninth) Liability Binder of Insurance.Compensatory plan or arrangement

     * Compensatory plan or arrangement

B.Reports on Form 8-K:
During the quarter ended June 30, 2004, the Company did not file any Current Reports on Form 8-K. During the quarter ended June 30, 2004, the Company furnished reports on Form 8-K pursuant to Item 9 (“Regulation FD Disclosure”) dated April 1, 2004, relating to the sale of Sunny Delight and Punica juice-based drink businesses; dated April 26, 2004, relating to an alternative to the Wella Dividend Proposal; dated April 26, 2004, relating to the announcement that the Company has entered into a Domination and Profit Transfer Agreement with Wella AG; dated April 30, 2004, relating to the announcement that court appointed independent auditor, Ernst & Young, has confirmed the cash offer and annual compensation payment to be offered by P&G as part of its Domination and Profit Transfer Agreement with Wella AG; dated May 11, 2004, relating to the Company purchasing the remaining stake in its China joint venture; dated May 19, 2004, relating to some business unit realignments and associated management changes; dated June 10, 2004, relating to updating previously issued guidance for the April-June 2004 quarter; and dated June 14, 2004, relating to the announcement that the Domination and Profit Transfer Agreement between the Company and Wella AG has become effective. The Company also furnished reports on Form 8-K containing information pursuant to Item 12 (“Results of Operations and Financial Condition”) dated April 30, 2004, relating to earnings for the quarter ended March 31, 2004.

1621


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Cincinnati, State of Ohio.
     
 THE PROCTER & GAMBLE COMPANY
 By:  A.G. LAFLEY   
ByA.G. LAFLEY

  (A.G. Lafley)
  
  Chairman of the Board, President and Chief Executive 
  August 29, 2006 President and Chief Executive
September 7, 2004

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons in the capacities and on the dates indicated.
     
Signature
 Title
 Date
A.G. LAFLEY

(A.G. Lafley)
 Chairman of the Board,
President and Chief Executive
(Principal (Principal Executive Officer)
 September 7, 2004August 29, 2006
CLAYTON C. DALEY, JR.

(Clayton C. Daley, Jr.)
 Chief Financial Officer
(Principal (Principal Financial Officer)
 September 7, 2004August 29, 2006
JOHN K. JENSEN

VALARIE L. SHEPPARD
(John K. Jensen)Valarie L. Sheppard)
 Vice President and Comptroller
(Principal (Principal Accounting Officer)
 September 7, 2004August 29, 2006
NORMAN R. AUGUSTINE

(Norman R. Augustine)
 Director September 7, 2004August 29, 2006
BRUCE L. BYRNES

(Bruce L. Byrnes)
 Director September 7, 2004August 29, 2006
R. KERRY CLARK

(R. Kerry Clark)
 Director September 7, 2004
SCOTT D. COOK

(Scott D. Cook)
 Director September 7, 2004August 29, 2006
DOMENICO DESOLE

(Domenico DeSole)
 Director September 7, 2004
JOSEPH T. GORMAN

(Joseph T. Gorman)
 Director September 7, 2004August 29, 2006

1722


     
Signature
 Title
 Date
JAMES M. KILTS
(James M. Kilts)
DirectorAugust 29, 2006
CHARLES R. LEE

(Charles R. Lee)
 Director September 7, 2004August 29, 2006
LYNN M. MARTIN

(Lynn M. Martin)
 Director September 7, 2004August 29, 2006
W. JAMES MCNERNEY, JR.

(W. James McNerney, Jr.)
 Director September 7, 2004August 29, 2006
JOHNATHAN A. RODGERS

(Johnathan A. Rodgers)
 Director September 7, 2004August 29, 2006
JOHN F. SMITH, JR.

(John F. Smith, Jr.)
 Director September 7, 2004August 29, 2006
RALPH SNYDERMAN, M.D.

(Ralph Snyderman, M.D.)
 Director September 7, 2004August 29, 2006
ROBERT D. STOREY

(Robert D. Storey)
 Director September 7, 2004
MARGARET C. WHITMAN

(Margaret C. Whitman)
 Director September 7, 2004August 29, 2006
ERNESTO ZEDILLO

(Ernesto Zedillo)
 Director September 7, 2004August 29, 2006

1823


EXHIBIT INDEX
   
Exhibit(3-1) Amended Articles of Incorporation (Incorporated by reference to Exhibit (3-1) of the Company’s Annual Report on Form 10-K10-Q for the yearquarter ended JuneSeptember 30, 2003)2005).
   
(3-2) Regulations (Incorporated by reference to Exhibit (3-2) of the Company’s Annual Report on Form 10-K10-Q for the yearquarter ended JuneSeptember 30, 2003)2005).
   
Exhibit(4) Registrant agrees to file a copy of documents defining the rights of holders of long-term debt upon request of the Commission.
   
Exhibit(10-1) The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended December 10, 2002)on February 14, 2006) which was adopted by shareholders at the annual meeting on October 9, 2001 (Incorporated by reference to Exhibit (10-1) of the Company’s Form 10-Q for the quarter ended March 31, 2006), and related correspondence and terms and conditions.conditions (Incorporated by reference to Exhibit (10-2) of the Company’s Form 10-Q for the quarter ended March 31, 2006).
   
(10-2) The Procter & Gamble 1992 Stock Plan (as amended December 11, 2001) which was adopted by the shareholders at the annual meeting on October 12, 1992 (Incorporated by reference to Exhibit (10-2) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).
   
(10-3) The Procter & Gamble Executive Group Life Insurance Policy (each executive officer is covered for an amount equal to annual salary plus bonus) (Incorporated by reference to Exhibit (10-3) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).
   
(10-4) Additional Remuneration Plan (as amended July 11, 2000) which was adopted by the Board of Directors on April 12, 1949, and related correspondence and terms and conditions (Incorporated by reference to Exhibit (10-4) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2000)2005).
   
(10-5) The Procter & Gamble Deferred Compensation Plan for Directors which was adopted by the Board of Directors on September 9, 1980 (Incorporated by reference to Exhibit (10-5) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).


   
(10-6) The Procter & Gamble 1993 Non-Employee Directors’ Stock Plan (as amended September 10, 2002) which was adopted by the shareholders at the annual meeting on October 11, 1994 (Incorporated by reference to Exhibit (10-6) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).
   
(10-7) The Procter & Gamble 1992 Stock Plan (Belgian Version) (as amended December 11, 2001) which was adopted by the Board of Directors on February 14, 1997 (Incorporated by reference to Exhibit (10-7) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003).
   
(10-8) The Procter & Gamble Future Shares Plan (as amended June 10, 2003)adjusted for the stock split effective May 21, 2004) which was adopted by the Board of Directors on October 14, 1997 (Incorporated by reference to Exhibit (10-8)(10-2) of the Company’s Form 10-Q for the quarter ended March 31, 2005).
(10-9)The Procter & Gamble 2003 Non-Employee Directors’ Stock Plan (as adjusted for the stock split effective May 21, 2004) which was adopted by the shareholders at the annual meeting on October 14, 2003 (Incorporated by reference to Exhibit (10-3) of the Company’s Form 10-Q for the quarter ended March 31, 2005), and related correspondence and terms and conditions (Incorporated by reference to Exhibit (10-9) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2003)2004).
(10-10)The Procter & Gamble Company Executive Deferred Compensation Plan (Incorporated by reference to Exhibit (10-1) of the Company’s Form 10-Q for the quarter ended December 31, 2005).
(10-11)Summary of the Company’s Short Term Achievement Reward Program and Business Growth Program, and related correspondence and terms and conditions (Incorporated by reference to Exhibit (10-11) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2005).
(10-12)Summary of personal benefits available to certain officers and non-employee directors (Incorporated by reference to Exhibit (10-12) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2005).
(10-13)$24,000,000,000 Revolving Credit Agreement among Procter & Gamble International S.a.r.l and a syndicate of banks led by Citigroup (Incorporated by reference to Exhibit (10-13) of the

 


   
(10-9) — The Procter & Gamble 2003 Non-Employee Directors’ Stock Plan, and related correspondence and terms and conditions.
   Company’s Annual Report on Form 10-K for the year ended June 30, 2005).
(10-10)
(10-14) The Gillette Company 1971 Stock Option Plan (Incorporated by reference to Exhibit (10-2) of the Company’s Form 10-Q for the quarter ended December 31, 2005).
(10-15)The Gillette Company 2004 Long-Term Incentive Plan (Incorporated by reference to Exhibit (10-3) of the Company’s Form 10-Q for the quarter ended December 31, 2005).
(10-16)Amended and Restated Employment Agreement, dated December 23, 2004, between The Gillette Company and James M. Kilts (Incorporated by reference to Exhibit 10(g) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).
(10-17)Amendment No. 1 to the Amended and Restated Employment Agreement dated as of December 23, 2004, entered into as of January 27, 2005, between The Gillette Company and James M. Kilts (Incorporated by reference to Exhibit 10.2 of the Form 8-K filed by The Gillette Company on January 28, 2005, Commission File No. 1-922).
(10-18)Stock Option Agreement, dated January 19, 2001, between The Gillette Company and James M. Kilts, filed as Exhibit A to the Amended and Restated Employment Agreement between The Gillette Company and James M. Kilts (Incorporated by reference to Exhibit 10(g) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).
(10-19)The Gillette Company Executive Life Insurance Program.
(10-20)The Gillette Company Personal Financial Planning Reimbursement Program (Incorporated by reference to Exhibit 10(o) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).
(10-21)The Gillette Company Senior Executive Financial Planning Program (Incorporated by reference to Exhibit 10(p) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).


(10-22)The Gillette Company Estate Preservation Plan (Incorporated by reference to Exhibit (10-22) of the Company’s Form 10-Q for the quarter ended December 31, 2005).
(10-23)The Gillette Company Deferred Compensation Plan (Incorporated by reference to Exhibit 10(t) of the Annual Report on Form 10-K filed by The Gillette Company for the year ended December 31, 2004, Commission File No. 1-922).
(10-24)Employment Agreement dated July 28, 2006 between The Procter & Gamble Company Executive Deferred Compensation Plan.and Mark M. Leckie.
   
Exhibit(11) Computation of earnings per share.
   
Exhibit(12) Computation of ratio of earnings to fixed charges.
   
Exhibit(13) Annual Report to Shareholders (pages 1-70)1-68).
   
Exhibit(21) Subsidiaries of the registrant.
   
Exhibit (23) — Independent Auditors’ Consent.
   
Exhibit(23)Consent of Independent Registered Public Accounting Firm.
Exhibit(31) Rule 13a-14(a)/15d-14(a) Certifications.
   
Exhibit(32) Section 1350 Certifications.
   
Exhibit (99-1) — Directors and Officers Liability Policy (Incorporated by reference to Exhibit (99-1) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2001).
   
(99-2) Exhibit(99-1) Summary of Directors and Officers (First) Liability Binder of Insurance.
(99-3) —Directors and Officers (Second) Liability Binder of Insurance.
(99-4) —Directors and Officers (Third) Liability Binder of Insurance.
(99-5) —Directors and Officers (Fourth) Liability Binder of Insurance.
(99-6) —Directors and Officers (Fifth) Liability Binder of Insurance.
(99-7) —Directors and Officers (Sixth) Liability Binder of Insurance.
(99-8) —Directors and Officers (Seventh) Liability Binder of Insurance.
(99-9) —Directors and Officers (Eighth) Liability Binder of Insurance.
(99-10) —Directors and Officers (Ninth) Liability Binder of Insurance.Insurance Program.